Beyond the review: additional non-oncologic drugs with clinically significant cardiovascular effects.

Lorenz, V.d.L. & Thomas, V. (2026). Beyond the review: additional non-oncologic drugs with clinically significant cardiovascular effects.. Eur Heart J Cardiovasc Pharmacother. https://doi.org/10.1093/ehjcvp/pvag029

Lorenz VdL, Thomas V. Beyond the review: additional non-oncologic drugs with clinically significant cardiovascular effects.. Eur Heart J Cardiovasc Pharmacother. 2026; doi: 10.1093/ehjcvp/pvag029

Lorenz VdL, Thomas V. Beyond the review: additional non-oncologic drugs with clinically significant cardiovascular effects.[J]. Eur Heart J Cardiovasc Pharmacother. 2026. DOI: 10.1093/ehjcvp/pvag029.

@article{lorenz2026,
  author = {Van der Linden Lorenz and Vanassche Thomas},
  title = {Beyond the review: additional non-oncologic drugs with clinically significant cardiovascular effects.},
  journal = {Eur Heart J Cardiovasc Pharmacother},
  year = {2026},
  doi = {10.1093/ehjcvp/pvag029},
  note = {PMID: 42033758},
}

TY  - JOUR
AU  - Van der Linden Lorenz
AU  - Vanassche Thomas
TI  - Beyond the review: additional non-oncologic drugs with clinically significant cardiovascular effects.
T2  - Eur Heart J Cardiovasc Pharmacother
PY  - 2026
DO  - 10.1093/ehjcvp/pvag029
AN  - PMID:42033758
ER  -